Inovio Pharmaceuticals Inc (INO)

[cameron12x]

It's ALL going to be about combination therapies to achieve the desired outcomes in the future.

I see Inovio leading the way with basic vaccine research, and the delivery mechanism (electroporation) to provide the robust T-cell uptake needed. Their patentable synthetic DNA will add to their patent portfolio and overall platform and pipeline. Other players can handle the rest. I could be wrong, but I personally don't believe INO will do everything alone.

That's why in the short-term we will likely need to take on additional partnerships and also why big pharma will need to partner with us. New partnerships WILL happen and I also expect that we could be purchased for north of $10B within two years, if not sooner.

If big pharma waits longer than that the price will be too large. Inovio is in excellent shape to become a leading biotech company and a household name within just a few years.